These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9920278)

  • 1. Cancer multidrug resistance.
    Persidis A
    Nat Biotechnol; 1999 Jan; 17(1):94-5. PubMed ID: 9920278
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in cancer: role of ATP-dependent transporters.
    Gottesman MM; Fojo T; Bates SE
    Nat Rev Cancer; 2002 Jan; 2(1):48-58. PubMed ID: 11902585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.
    Dantzig AH; Shepard RL; Law KL; Tabas L; Pratt S; Gillespie JS; Binkley SN; Kuhfeld MT; Starling JJ; Wrighton SA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):854-62. PubMed ID: 10411602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
    Aszalos A; Ross DD
    Anticancer Res; 1998; 18(4C):2937-44. PubMed ID: 9713488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
    Ueda K
    Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance.
    Moscow JA; Schneider E; Ivy SP; Cowan KH
    Cancer Chemother Biol Response Modif; 1997; 17():139-77. PubMed ID: 9551213
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug resistance.
    Schneider E; Paul D; Ivy P; Cowan KH
    Cancer Chemother Biol Response Modif; 1999; 18():152-77. PubMed ID: 10800482
    [No Abstract]   [Full Text] [Related]  

  • 10. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance.
    Moscow JA; Schneider E; Cowan KH
    Cancer Chemother Biol Response Modif; 1996; 16():111-31. PubMed ID: 8639380
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
    Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical resistance mechanisms.
    Jäeger W
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):46-8. PubMed ID: 19203536
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of the fluoroquinolone ofloxacin on the intrinsic expression of multidrug resistance phenotype in HCT-8 human colon carcinoma cells.
    Marchal S; Merlin JL; Colosetti P; Finance C
    Oncol Res; 1999; 11(8):375-81. PubMed ID: 10803741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
    Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
    Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.